ArrowMark Financial Corp. Announces Q3 2024 Results and Releases Month End Estimated Net Asset Value as of November 2024

Stock Information for abrdn Life Sciences Investors Shares of Beneficial Interest

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About abrdn Life Sciences Investors Shares of Beneficial Interest

ArrowMark Financial Corp. Announces Q3 Results and Special Distribution of $0.10 and Regular Cash Distribution of $0.45 per Share for the Fourth Quarter 2025
ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of October 2025
ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value As of September 2025
ArrowMark Financial Corp. Appoints Melissa Marano Thompson to the Company's Board of Directors
ArrowMark Financial Corp. Announces Q2 Results and Special Distribution of $0.40 and Regular Cash Distribution of $0.45 per Share for the Third Quarter 2025
ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of August 2025
ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of July 2025
ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of June 2025

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.